Riskpilot← Back to searchSign inGet full accessGluggen ögontjänst AB
ABActiveOrg 5568634140Fogdegatan 14Medical specialists activities · NACE 8622Est. 20111 employees
Revenue 2025
SEK 5,7M
+22% vs 2024
EBITDA margin
67.3%
+36% vs 2024
Equity ratio
96.9%
Financial strength
Net profit 2025
SEK 3M
+31% vs 2024
| Revenue | SEK 5,7M | +22% |
| EBITDA | SEK 3,8M | +36% |
| Net profit | SEK 3M | +31% |
| Total assets | SEK 17,7M | +15% |
| Equity | SEK 17,2M | +16% |
| Employees | 1 | — |
Legal name
Gluggen ögontjänst AB
Org number
5568634140
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
5 september 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är ögonsjukvård samt uppdrag åt läkemedelsföretag och föreningar inom detta område och därmed förenlig verksamhet. Bolaget ska äga, förvalta och hyra ut egna bostadsrätter och därmed förenlig verksamhet.
Address
Fogdegatan 14
Email
hans.huskvarna@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 707 | 4 114 | 4 216 | 4 628 | 5 666 |
| Staff expenses | — | — | — | — | −1 649 |
| EBITDA | 1 441 | 1 936 | 2 817 | 2 795 | 3 814 |
| Depreciation & amort. | −19 | −19 | −21 | −23 | −105 |
| EBIT | 1 422 | 1 917 | 2 796 | 2 772 | 3 708 |
| Net financials | 47 | −7 | 390 | 120 | 75 |
| Profit before tax | 1 469 | 1 910 | 3 186 | 2 892 | 3 784 |
| Tax | −306 | −394 | −663 | −596 | −781 |
| Net profit | 1 163 | 1 516 | 2 523 | 2 296 | 3 002 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 11 201 | 11 800 | 13 576 | 15 369 | 17 743 |
| Equity | 10 311 | 11 227 | 13 250 | 14 846 | 17 199 |
| Long-term debt | 353 | 113 | 0 | 0 | — |
| Short-term debt | 538 | 460 | 325 | 523 | 544 |
| Total debt | 891 | 573 | 325 | 523 | 544 |
EBITDA margin
67.3%
This company
15.8%
Market median
+326% vs market
20212025
Equity ratio
96.9%
This company
38.2%
Market median
+154% vs market
20212025
Return on equity
17.5%
This company
18.4%
Market median
+5% vs market
20212025
Net profit margin
53.0%
This company
8.1%
Market median
+554% vs market
20212025
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
20212025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AE | Audit | 2024 |
| Former (1) | ||
OE | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Gluggen ögontjänst AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alexander Erik Palmér | Audit | 0 companies |
| Olof Einar Mikael Björklund | Audit | 0 companies |
| Hans Erik Eriksson | Board of Directors | 0 companies |
| Elisabeth Marie Berit Milton | Deputy Board Member | 0 companies |
| Filip Albert Eriksson | Deputy Board Member | 0 companies |